Literature DB >> 25265236

Conditional control of mammalian gene expression by tetracycline-dependent hammerhead ribozymes.

Kim Beilstein1, Alexander Wittmann1, Manuel Grez2, Beatrix Suess1.   

Abstract

Robust synthetic devices are requisite for the construction of synthetic genetic circuits and important scientific and technological tools to control cellular processes. We developed tetracycline-dependent ribozymes, which can switch on gene expression up to 8.7-fold upon addition of tetracycline. A tetracycline aptamer was grafted onto the hammerhead ribozyme in such a way that ligand binding to the aptamers destroys a loop-loop interaction within the ribozyme thereby inhibiting ribozyme cleavage and allowing gene expression. The advantage of the presented regulatory system is its independence of any regulatory proteins. The stable integration of the ribozyme into the genome of HeLa cells indicates a low background activity in the absence of ligand. Furthermore, the ligand concentration required to robustly flip the switch does not affect cell viability and therefore allows a long-term application of the system. These properties turn the tetracycline-dependent ribozymes into a very promising tool for conditional gene expression in mammalian cells.

Entities:  

Keywords:  HeLa cells; aptamer; engineered riboswitch; ribozyme; synthetic biology; tetracycline

Mesh:

Substances:

Year:  2014        PMID: 25265236     DOI: 10.1021/sb500270h

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  35 in total

1.  Detection of Low-Abundance Metabolites in Live Cells Using an RNA Integrator.

Authors:  Mingxu You; Jacob L Litke; Rigumula Wu; Samie R Jaffrey
Journal:  Cell Chem Biol       Date:  2019-02-14       Impact factor: 8.116

2.  A Theophylline-Responsive Riboswitch Regulates Expression of Nuclear-Encoded Genes.

Authors:  Nana Shanidze; Felina Lenkeit; Jörg S Hartig; Dietmar Funck
Journal:  Plant Physiol       Date:  2019-11-08       Impact factor: 8.340

3.  Conditional control of suicide gene expression in tumor cells with theophylline-responsive ribozyme.

Authors:  Y Zhang; J Wang; H Cheng; Y Sun; M Liu; Z Wu; R Pei
Journal:  Gene Ther       Date:  2016-11-22       Impact factor: 5.250

4.  Highly motif- and organism-dependent effects of naturally occurring hammerhead ribozyme sequences on gene expression.

Authors:  Lena A Wurmthaler; Benedikt Klauser; Jörg S Hartig
Journal:  RNA Biol       Date:  2017-12-08       Impact factor: 4.652

5.  Riboswitch-mediated Attenuation of Transgene Cytotoxicity Increases Adeno-associated Virus Vector Yields in HEK-293 Cells.

Authors:  Benjamin Strobel; Benedikt Klauser; Jörg S Hartig; Thorsten Lamla; Florian Gantner; Sebastian Kreuz
Journal:  Mol Ther       Date:  2015-07-03       Impact factor: 11.454

6.  What defines a synthetic riboswitch? - Conformational dynamics of ciprofloxacin aptamers with similar binding affinities but varying regulatory potentials.

Authors:  Christoph Kaiser; Jeannine Schneider; Florian Groher; Beatrix Suess; Josef Wachtveitl
Journal:  Nucleic Acids Res       Date:  2021-04-19       Impact factor: 16.971

7.  Next-level riboswitch development-implementation of Capture-SELEX facilitates identification of a new synthetic riboswitch.

Authors:  Adrien Boussebayle; Daniel Torka; Sandra Ollivaud; Johannes Braun; Cristina Bofill-Bosch; Max Dombrowski; Florian Groher; Kay Hamacher; Beatrix Suess
Journal:  Nucleic Acids Res       Date:  2019-05-21       Impact factor: 16.971

8.  Dynamic nuclear polarization of nucleic acid with endogenously bound manganese.

Authors:  Patricia Wenk; Monu Kaushik; Diane Richter; Marc Vogel; Beatrix Suess; Björn Corzilius
Journal:  J Biomol NMR       Date:  2015-07-29       Impact factor: 2.835

9.  Small synthetic molecule-stabilized RNA pseudoknot as an activator for -1 ribosomal frameshifting.

Authors:  Saki Matsumoto; Neva Caliskan; Marina V Rodnina; Asako Murata; Kazuhiko Nakatani
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

10.  Riboswitching with ciprofloxacin-development and characterization of a novel RNA regulator.

Authors:  Florian Groher; Cristina Bofill-Bosch; Christopher Schneider; Johannes Braun; Sven Jager; Katharina Geißler; Kay Hamacher; Beatrix Suess
Journal:  Nucleic Acids Res       Date:  2018-02-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.